| Patents for C07K 16 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies (149,320) |
|---|
| 03/01/2001 | WO2001013714A2 Prostatic cell line and animal model of a prostatic tumor |
| 03/01/2001 | WO2000077208A3 Gustatory receptors in drosophila |
| 03/01/2001 | WO2000073449B1 Dna encoding snorf33 receptor |
| 03/01/2001 | WO2000073445A3 Interleukin-1-receptor associated kinase-3 (irak3) |
| 03/01/2001 | WO2000066619A3 Means and methods for altering the functional properties in eukaryotic cells |
| 03/01/2001 | WO2000049038A3 Synthetic peptide of regulatory virus protein r (vpr) of human immunodeficiency virus type 1 (hiv-1) and the utilization thereof |
| 03/01/2001 | WO2000048638A3 Multi-mutant diphtheria toxin vaccines |
| 03/01/2001 | WO2000043774A3 Detection of small molecules by use of a piezoelectric sensor |
| 03/01/2001 | WO2000029434A3 PNEUMOCOCCAL CHOLINE BINDING PROTEINS, CbpG AND CbpD, DIAGNOSTIC AND THERAPEUTIC USES THEREOF |
| 03/01/2001 | WO1999040214A8 Nucleic acid delivery vehicles |
| 03/01/2001 | WO1999036537A3 Fatty acid transport proteins |
| 03/01/2001 | CA2589418A1 Human ctla-4 antibodies and their uses |
| 03/01/2001 | CA2383456A1 Pd-1, a receptor for b7-4, and uses therefor |
| 03/01/2001 | CA2383074A1 Novel abc transporter and uses thereof |
| 03/01/2001 | CA2383063A1 Human abc2 transporter and uses thereof |
| 03/01/2001 | CA2382795A1 Homologs of a pneumococcal protein and fragments for vaccines |
| 03/01/2001 | CA2382783A1 A polynucleotide encoding a human junctional adhesion protein (jam-2) |
| 03/01/2001 | CA2382674A1 Gas1 polypeptides |
| 03/01/2001 | CA2382587A1 Hm1.24 antigen expression potentiators |
| 03/01/2001 | CA2382221A1 Outer membrane protein a, peptidoglycan-associated lipoprotein, and murein lipoprotein as therapeutic targets for treatment of sepsis |
| 03/01/2001 | CA2382204A1 Prostatic cell line and use thereof to obtain an established prostatic cancer in an animal |
| 03/01/2001 | CA2382183A1 New g-protein coupled receptor and dna sequences thereof |
| 03/01/2001 | CA2382146A1 Pgrp-l polynucleotides, polypeptides, and antibodies |
| 03/01/2001 | CA2382123A1 Novel polynucleotides expressed in activated t-lymphocytes and proteins encoded thereby |
| 03/01/2001 | CA2381099A1 Melanoma associated antigen (hmw-maa) defined by a monoclonal antibody |
| 03/01/2001 | CA2376406A1 G protein-coupled receptor expressed in brain |
| 02/28/2001 | EP1078266A1 HUMAN CHROMOGRANIN A (GgA) IMMUNOLOGIC ASSAY, ANTIBODIES, REAGENTS AND KITS FOR SAID ASSAY |
| 02/28/2001 | EP1078259A2 Diagnostic tests for alzheimer's disease |
| 02/28/2001 | EP1078099A1 Identifying peptide ligands of target proteins with target complementary library technology (tclt) |
| 02/28/2001 | EP1078082A1 Enzymatically-active recombinant human beta-tryptase and method of making same |
| 02/28/2001 | EP1078076A2 Novel nucleic acids and polypeptides related to a farnesyl-directed endopeptidase |
| 02/28/2001 | EP1078073A1 Chitinase chitin-binding fragments |
| 02/28/2001 | EP1078070A2 Human nucleic acid methylases |
| 02/28/2001 | EP1078064A2 Compounds from moraxella catarrhalis |
| 02/28/2001 | EP1078063A2 Basb029polynucleotide(s) and polypeptides from neisseria meningitis |
| 02/28/2001 | EP1078062A2 Growth-associated protease inhibitor heavy chain precursor |
| 02/28/2001 | EP1078060A2 Antibodies to dendritic cells and human dendritic cell populations and uses thereof |
| 02/28/2001 | EP1078058A2 Prostate growth-associated membrane proteins |
| 02/28/2001 | EP1078057A2 Cell signaling proteins |
| 02/28/2001 | EP1078056A1 Rhotekin, a putative target for rho |
| 02/28/2001 | EP1078046A1 97 human secreted proteins |
| 02/28/2001 | EP1078040A1 Nt2lp, novel g-protein coupled receptors having homology to neurotensin-2 receptors |
| 02/28/2001 | EP1078006A1 Diagnosis and treatment of hepatic disorders |
| 02/28/2001 | EP1078005A1 Methods for amyloid removal using anti-amyloid antibodies |
| 02/28/2001 | EP1077999A2 Moraxella catharralis proteins |
| 02/28/2001 | EP1077996A1 HUMAN EDG3sb GENE |
| 02/28/2001 | EP1077989A1 Tumor associated antigen encoded by the reverse strand of a new ubiquitously expressed gene |
| 02/28/2001 | EP1077983A2 Pria |
| 02/28/2001 | EP1077723A1 Methods and use of compositions comprising tnf-rii(p75) agonists for treating asthma and other allergic conditions |
| 02/28/2001 | EP1077721A1 Prevention and treatment of hypergastrinemia |
| 02/28/2001 | EP1077600A1 Production of biomedical peptides and proteins in plants using plant virus vectors |
| 02/28/2001 | EP0851939A4 Methods for labeling dna ends with halogenated nucleotides and detecting same with antibodies |
| 02/28/2001 | EP0695192B1 Gonococcal anti-idiotypic antibodies and methods and compositions using them |
| 02/28/2001 | EP0672142B1 Multivalent and multispecific binding proteins, their manufacture and use |
| 02/28/2001 | EP0594710B1 Tyrosine kinase |
| 02/28/2001 | CN1285874A Desaturase genes and their use |
| 02/28/2001 | CN1285754A Monoclonal human matural antibodies |
| 02/28/2001 | CN1285514A Medicine box bof testing anti-hepatitis C virus antibody |
| 02/28/2001 | CN1285513A Method for testing or determining HCV core antigen and the agent for same |
| 02/28/2001 | CN1062600C Process for preparation selenic antibody enzyme |
| 02/28/2001 | CN1062566C Nuclide marked immunoglobulin M monoantibody segment |
| 02/27/2001 | US6194561 Oligonucleotide probes of defined nucleotide sequences which are complementary to second exon of class ii hla beta chain gene; diagnosis of susceptibility to insulin-dependent diabetes mellitus and pemphigus vulgaris; antidiabetic agents |
| 02/27/2001 | US6194560 Synthetic escherichia coli gene which encodes lt-b; the dna sequence is optimized for plant codon usage; feeds; foods |
| 02/27/2001 | US6194552 Masking antitope of antibody with orientation directing agent to form complex, then immobilizing complex on support so that antitope is oriented away from support; improved binding efficiency |
| 02/27/2001 | US6194551 Polypeptide variants |
| 02/27/2001 | US6194549 Partially purified preparation of pen5, a glycoprotein pair; for detecting and/or removing natural killer cells from a mixed population of cells |
| 02/27/2001 | US6194542 Method of detecting cytomegalovirus (CMV) |
| 02/27/2001 | US6194385 Calcium-binding protein |
| 02/27/2001 | US6194376 Method for modulating inflammatory response comprising administering morphogen |
| 02/27/2001 | US6194190 From pyrococcus which can release two or more blocking groups selected from acetyl group, pyroglutamyl group, formyl group and myristoyl group, from protected peptides; use in kits for analyzing an amino acid sequence |
| 02/27/2001 | US6194187 Apoptosis-inducing protein and gene encoding the same |
| 02/27/2001 | US6194186 Human protein kinase and kinase inhibitors |
| 02/27/2001 | US6194172 Cytokine designated lerk-6 |
| 02/27/2001 | US6194171 Also vectors, transformed cells; useful for expression in cells for the purposes of identifying agonists or antagonists of ataxin-2-binding protein function |
| 02/27/2001 | US6194166 Isolated dna; genetic engineering |
| 02/27/2001 | US6194163 Method for the quantitative measurement of human acute phase serum amyloid A protein; recombinant protein; specific antibody |
| 02/27/2001 | US6194162 Method of screening for compounds that bind P2x receptor |
| 02/27/2001 | US6194161 Staphylococcus aureus antigen |
| 02/27/2001 | US6194153 Methods for determining risk of developing alzheimer's disease by detecting mutations in the presenilin 1 (PS-1) gene |
| 02/27/2001 | US6194152 Nucleotide sequences for the diagnosis and treatment of human urogenital cancers |
| 02/27/2001 | US6194151 Nucleotide sequences coding binding polypeptide; for the detection of modulators of tumor necrosis factor activity; for the treatment of cell proliferation and differentiation defects |
| 02/27/2001 | US6194142 Nucleotide sequences derived from the genome of retroviruses of the HIV-1, HIV-2, and SIV type, and their uses in particular for the amplification of the genomes of these retroviruses and for the in vitro diagnosis of the diseases due to these viruses |
| 02/27/2001 | US6193982 Anti-cyanovirin antibody with an internal image of gp120, a method of use thereof, and a method of using a cyanovirin to induce an immune response to gp120 |
| 02/27/2001 | US6193981 Methods and compositions for impairing multiplication of HIV-1 |
| 02/27/2001 | US6193972 Hybrid heterodimeric protein hormone |
| 02/27/2001 | US6193969 Preventing, ameliorating, or treating septic shock or its symptoms by administering igg (immunoglobulin g) fab fragments reactive towards tnf.alpha.(tumor nercosis factor), wherein igg fab fragments are derived from polyclonal igg |
| 02/27/2001 | US6193968 Methods for using anti-αvβ3 integrin antibody |
| 02/27/2001 | US6193967 Administering bispecific molecule, comprising: binding specificity for human high density lipoprotein (hdl), or fragment and for an fc.gamma. receptor for immunoglobulin g for treating and prophylaxis of atherosclerosis |
| 02/27/2001 | US6193966 Administering bispecific protein or peptide molecule, comprising a first binding determinate which binds to fc.alpha.receptor without being blocked by immunoglobulin a and second binding determinant which binds to target antigen |
| 02/27/2001 | US6193965 Administering therapeutically effective amount of reagent which modulates kinase activity for treating cell proliferative disorder associated with c-jun n-terminal kinase disorder, |
| 02/27/2001 | US6193963 Method of treating tumor-bearing patients with human plasma hyaluronidase |
| 02/27/2001 | US6193948 Contacting sample with purified hu antigenic polypeptide to form complex between purified hu antigenic polypeptide and antibody, detecting presence of complex formed to detect antibody associated with paraneoplastic sensory neuronopathy |
| 02/27/2001 | CA2066031C Methods for reducing non-target retention of immunoconjugates and metabolites thereof |
| 02/27/2001 | CA1341191C Detection of neu gene expression and products |
| 02/22/2001 | WO2001013122A2 Method for monitoring beta tubulin isotype modification |
| 02/22/2001 | WO2001013117A2 Proteins, genes and their use for diagnosis and treatment of breast cancer |
| 02/22/2001 | WO2001013110A2 Detection of isomerised epitopes in autoimmune diseases |
| 02/22/2001 | WO2001012847A2 Isolation of cells from forensic samples for dna-typing |
| 02/22/2001 | WO2001012840A2 Anti-epha2 antibodies as a cancer diagnostic |
| 02/22/2001 | WO2001012819A2 Protein phosphatases and diagnosis and treatment of phosphatase-related disorders |